RecruitingNot Applicable

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Turkey (Türkiye)117 participantsStarted 2025-12-15

Plain-language summary

Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention. The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years. The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group. Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained. Research Questions Does HPV education delivered through different methods increase HPV knowledge levels among young women? Does HPV education increase HPV vaccination intention compared with the control group? Is face-to-face education more effective than video-based education in increasing vaccination intention? Are the improvements in knowledge and vaccination intention sustained one month after the education?

Who can participate

Age range

18 Years – 24 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Participants must meet all of the following criteria to be included in the study: Aged 18-24 years, Residing in Afşin district, Kahramanmaraş province, Willing to voluntarily participate in the study, Literate and able to understand survey questions in Turkish, Have not previously received the HPV vaccine, Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test), Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study. Exclusion Criteria: Participants will be excluded if they meet any of the following conditions: Under 18 or over 24 years of age, Have received the HPV vaccine or started the vaccine series, Have been diagnosed with HPV infection, Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test), Illiterate or unable to understand the study forms in Turkish, Withdraw from the study or indicate unwillingness to continue participation, Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

HPV Knowledge and Vaccination Intention - Pre-Test

Timeframe: Before education

Trial details

NCT IDNCT07420556

SponsorEmel GÜÇLÜ CİHAN

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-15

Contact for this trial

Emel Asst. Prof.

03443004913 emel_guclu4606@hotmail.com

View on ClinicalTrials.gov More Human Papillomavirus (HPV) Infection trials